Biofinity® family

Family products

Biofinity Energys® Monthly Replacement short-sightedness/long-sightedness*

Biofinity® XR Monthly Replacement short-sightedness/long-sightedness*

Biofinity® XR toric Monthly Replacement ASTIGMATISM†

Biofinity® toric multifocal Monthly Replacement ASTIGMATISM† PRESBYOPIA‡

Biofinity^® contact lenses are trusted by eye care professionals and loved by wearers worldwide.^§◊1,2 With world-class design and the unique Aquaform^® Technology, your patients can enjoy great vision, incredible comfort and a healthy lens-wearing experience^{.¶**††3,4}

Packaging images for illustration purposes only.

*With myopia (short-sightedness) or hyperopia (long-sightedness).
†With myopia or hyperopia with astigmatism.
‡ With myopia, hyperopia or emmetropia with presbyopia.
§ On average, 85% strongly/somewhat agree.
◊ On average, 84% strongly/somewhat agree.
¶ Applies only to patients wearing Biofinity^® family contact lenses.

References:

1. CVI data on file 2021. Decision Analyst online survey of 376 Biofinity^® prescribing ECPs in USA, Japan, Germany, France and Spain.
2. CVI data on file 2021. Decision Analyst online survey of 1,027 Biofinity^® wearers aged 16-65 years in USA, Japan, Germany, France and Spain.
3. CVI data on file, 2024.
4.CVI Data on file, 2024. CVI data on file, 2023; Based on global product sales and internal estimates of products using Aquaform^® Technology over 12 months in 2023.

SA14324/ APP150344